Pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) prevents severe SARS-CoV-2 infection in recipients of allogeneic hematopoietic stem cell transplantation during the Omicron wave: a multicentric retrospective study of SFGM-TC

Since the emergence of the Omicron variant of SARS-CoV-2, though considered less virulent, hospitalization and death rates among immunocompromised patients remain high, especially for poor responders to vaccination. We conducted a retrospective multicentric study to evaluate pre-exposure prophylaxis...

Descripción completa

Detalles Bibliográficos
Autores principales: Jondreville, Ludovic, D’Aveni, Maud, Labussière-Wallet, Hélène, Le Bourgeois, Amandine, Villate, Alban, Berceanu, Ana, Bezsera, Silvia-Maria, Thiebaut, Anne, Boissard-Simonet, Marion, Legrand, Marlène, Cornillon, Jérôme, Rubio, Marie-Thérèse, Chevallier, Patrice, Nguyen, Stéphanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702670/
https://www.ncbi.nlm.nih.gov/pubmed/36443846
http://dx.doi.org/10.1186/s13045-022-01387-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702670/
https://www.ncbi.nlm.nih.gov/pubmed/36443846
http://dx.doi.org/10.1186/s13045-022-01387-0

Ejemplares similares